Fairman Group, LLC
- SEC CIK
- 0002016719
- Latest filing
- Aug 4, 2026
VTGN holding history
Vistagen Therapeutics, Inc. in every 13F filed by Fairman Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VTGN overviewAll 13F holders of VTGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 29
- Value
- $7
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 29 | $7 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 29 | $17 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 29 | $19 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 29 | $103 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 29 | $58 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 29 | $86 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 29 | $86 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 29 | $87 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 29 | $101 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 29 | $153 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 29 | $149 | <0.1% | – | No prior filing | Holders |